Sinusoidal obstruction syndrome following CD33-targeted therapy in acute myeloid leukemia
نویسندگان
چکیده
منابع مشابه
Therapy-related myeloid leukemia following Pleuropulmonary blastoma: A case report
The development of secondary malignancy (SM) is the most worrisome long-term complication of childhood cancer. Acute myeloid leukemia is the most prevalent neoplasm that occurs after treatment with alkylating agents and topoisomerase II inhibitors. Pleuropulmonary blastoma (PPB) is a rare lung neoplasm in children. Type II and type III of this cancer are markedly aggressive and have a recurrent...
متن کاملAnti-CD33 chimeric antigen receptor targeting of acute myeloid leukemia.
Current therapies for acute myeloid leukemia are associated with high failure and relapse rates. Adoptive immunotherapies, which have shown promise in the treatment of hematologic malignancies, have the potential to target acute myeloid leukemia through pathways that are distinct and complementary to current approaches. Here, we describe the development of a novel adoptive immunotherapy specifi...
متن کاملReview Series ADVANCES IN ACUTE MYELOID LEUKEMIA Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia
Acute myeloid leukemia (AML) is the most common type of acute leukemia in adults. Despite current treatment protocols involving intensive chemotherapy and the judicious use of stem cell transplantation, AML is still fatal in approximately half of younger patients and in about 80% of patients over the age of 60 as a result of primary refractoriness, relapse, or treatment-related mortality. Conse...
متن کاملTherapy-related Acute Myeloid Leukemia Following Treatment for Burkitt's Lymphoma
https://doi.org/10.4068/cmj.2017.53.3.229 C Chonnam Medical Journal, 2017 Chonnam Med J 2017;53:229-230 Corresponding Author: Seung-Shin Lee Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, 322 Seoyang-ro, Hwasun 58128, Korea Tel: +82-61-379-7636, Fax: +82-61-379-7628, E-mail: [email protected] Article History: Received July 15, 2017 Revised July 30, 2017 Accepte...
متن کاملTherapy-related acute myeloid leukemia following treatment of lymphoid malignancies
Therapy-related acute myeloid leukemia (t-AML) is a heterogeneous entity most frequently related to breast cancer or lymphoproliferative diseases (LD). Population-based studies have reported an increased risk of t-AML after treatment of lymphomas. The aim of this study was to describe the characteristics and outcome of 80 consecutive cases of t-AML following treatment of LD. t-AML accounted for...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Blood
سال: 2017
ISSN: 0006-4971,1528-0020
DOI: 10.1182/blood-2017-01-762419